Assaf Halevy, Founder and CEO of 2bPrecise
Electronic medical records (EMRs) are widely expected to serve as a cornerstone technology that drives the delivery of modern patient care.
But can the EMR alone support all the informatics capabilities required by an ever-evolving healthcare industry? The rapid growth of precision medicine, particularly the use of genetic and genomic information during clinical decision making, is a compelling example that functionality beyond the EMR is
Read More
AMA Adds 3 Additional CPT Codes for AstraZeneca’s COVID-19 Vaccine
What You Should Know:
- The American Medical Association (AMA) announced the addition of three Current Procedural Terminology (CPT) codes for AstraZeneca's COVID-19 vaccine.
The American Medical Association (AMA) today announced that
the Current Procedural Terminology (CPT®) code set is
being updated by the CPT Editorial Panel to include immunization and
administration codes that are unique to the COVID-19 vaccine under development
by AstraZeneca and University of
Read More
AMA Adds New CPT Codes Multi-Virus Tests to Detect COVID-19 and Flu
What You Should Know:
- AMA
announces new CPT codes for multi-virus tests to detect COVID-19 and flu for
immediate use.
The American Medical Association (AMA) today published an update to the Current Procedural Terminology (CPT®) code set that includes new code additions and editorial revisions for reporting medical services sparked by the public health response to the COVID-19 pandemic. The update to the CPT code set was approved by the CPT Editorial Panel, the
Read More
Nebula Gives Users Ownership Of Their Personal Genomic Data with Oasis Integration
What You Should Know:
- Nebula Genomics announces integration with Oasis Labs to give its customers full ownership and control of the data received from their comprehensive genome sequencing tests.
- Through Oasis Labs’ unique privacy solution Parcel, Nebula’s
users will be able to retain ownership and control of their personal genomic data.
Data remains confidential, and users can grant access to their data for
specific use cases such as generation of reports offered by Nebula or
Read More
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
The DNA Company Acquires AI Digital Therapeutics App for $30M to Form My Next Health
What You Should Know:
- DNA Company acquires AI-based digital therapeutics app My Pain Sensei (MPS) to form My Next Health and is building a COVID-19 risk assessment platform to help people understand their risks of developing serious COVID-19 complications.
- The acquisition combines functional genomics with conversational AI for patient self-management apps and disease tracking tools designed to inform clinician-patient interactions.
Leading functional genomics provider The
Read More
FDA Approves Emergency Use Authorization for a 24-hour, Saliva Test for COVID-19
What You Should Know:
- The FDA has provided Emergency Use Authorization for a 24-hour, Saliva Test for COVID-19, available now to clinics, hospitals, and patients.
- In light of recent complications with and warnings for new tests, here is a quick list of information on the validated test and how it is different from existing testing and other alternatives in development:
- The saliva-based test for COVID-19 has been validated and proven as a consistent sample method.
- FDA
Read More
Stanford Alumni Scientists, Physicians Launch StartX Med COVID-19 Task Force
What You Should Know:
- More than 1500 Stanford faculty and alumni announced the launch of StartX Med COVID-19 Task Force featuring 70+ StartX Med Innovators with medical breakthroughs for the prevention, diagnostics, and treatment of coronavirus mobilize efforts to fast-track public health needs during the pandemic.
- The StartX Med COVID-19 Task Force will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health for
Read More
The Many Faces of AI in Clinical Trials
Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and
Read More
Rady Children’s Exploring Drone Delivery of Genomic Samples to Lab
- Deloitte and Rady’s Children’s Institute for Genomic Medicine (RCIGM) announced an innovative new project to explore the use of unmanned aircraft systems (UAS) known as drones to deliver genomic samples to the laboratory.- This approach seeks to cut down on ground traffic delays by flying genomic testing specimens to the lab, cutting the time needed to get results back to acutely ill babies and children.- The project is in the planning stages; Deloitte and RCIGM are working in coordination
Read More
